Intriguingly, analysis of the TCGA data showed that DPAGT1 expression was increased in multiple types of HER2-overexpressing human cancer (26), including breast cancer, gastric cancer, colorectal cancer, and uterine corpus endometrioid carcinoma. Here, DPAGT1 is linked to endometrial endometrioid adenocarcinoma.